Patient-Reported Outcome Measures in Dermatology: A Systematic Review.
burden
dermatology-specific
measurement properties
quality of life
patient-reported outcome measures
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
28 Sep 2021
28 Sep 2021
Historique:
pubmed:
16
7
2021
medline:
1
10
2021
entrez:
15
7
2021
Statut:
epublish
Résumé
By relying on data from existing patient-reported outcome measures of quality of life, the true impact of skin conditions on patients' lives may be underestimated. This study systematically reviewed all dermatology-specific (used across skin conditions) patient-reported outcome measures and makes evidence-based recommendations for their use. The study protocol is registered on PROSPERO (CRD42018108829). PubMed, PsycInfo and CINAHL were searched from inception to 25 June 2018. The Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) criteria were used to assess the measurement properties and methodological quality of studies. A total of 12,925 abstracts were identified. Zero patient-reported outcome measures were assigned to category A (ready for use without further validation), 31 to category B (recommended for use, but only with further validation) and 5 to category C (not recommended for use). There is no gold-standard dermatology-specific patient-reported outcome measure that can be recommended or used without caution. A new measure that can comprehensively capture the impact of dermatological conditions on the patient's life is needed.
Identifiants
pubmed: 34263330
doi: 10.2340/00015555-3884
pmc: PMC9425604
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv00559Références
Qual Life Res. 2006 Apr;15(3):565-70
pubmed: 16547795
J Eur Acad Dermatol Venereol. 2011 Feb;25(2):245-6; author reply 246
pubmed: 21118311
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Health Qual Life Outcomes. 2005 May 20;3:36
pubmed: 15907211
Arch Dermatol. 2002 Sep;138(9):1221-7; discussion 1227
pubmed: 12224984
J Eur Acad Dermatol Venereol. 2012 Oct;26(10):1252-7
pubmed: 21958389
J Invest Dermatol. 2012 Jan;132(1):76-84
pubmed: 21881588
G Ital Dermatol Venereol. 2016 Feb;151(1):37-43
pubmed: 24927171
Acta Derm Venereol. 2002;82(5):347-51
pubmed: 12430733
Arch Dermatol. 2012 Nov;148(11):1251-5
pubmed: 23165828
J Dermatolog Treat. 2017 Jun;28(4):347-352
pubmed: 27764972
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):109-15
pubmed: 22145712
J Am Acad Dermatol. 2001 Jul;45(1):44-8
pubmed: 11423833
Health Qual Life Outcomes. 2014 Dec 24;12:190
pubmed: 25539748
J Am Acad Dermatol. 1997 Jul;37(1):41-50
pubmed: 9216522
J Am Acad Dermatol. 2003 Jan;48(1):128-30
pubmed: 12522383
Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
Int J Dermatol. 2007 Mar;46(3):247-52
pubmed: 17343578
Syst Rev. 2015 Apr 16;4:48
pubmed: 25927828
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
J Eur Acad Dermatol Venereol. 2010 Apr;24 Suppl 2:17-22
pubmed: 20443996
Br J Dermatol. 1995 Jun;132(6):942-9
pubmed: 7662573
Qual Life Res. 1998 Dec;7(8):723-34
pubmed: 10097621
Dermatology. 2009;218(2):151-4
pubmed: 19060458
Qual Life Res. 2009 Oct;18(8):1115-23
pubmed: 19711195
Int J Dermatol. 2005 Nov;44(11):933-8
pubmed: 16336527
Acta Derm Venereol. 2018 Jan 12;98(1):59-64
pubmed: 28676885
Acta Derm Venereol. 2014 Nov;94(6):658-62
pubmed: 24604210
Br J Dermatol. 1997 Apr;136(4):502-7
pubmed: 9155948
Allergy. 2012 Sep;67(9):1111-7
pubmed: 22844983
Ann Allergy Asthma Immunol. 2004 Aug;93(2):142-6
pubmed: 15328673
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
Pediatr Allergy Immunol. 2020 Jan;31(1):66-77
pubmed: 31505076
Hautarzt. 2003 Sep;54(9):852-7
pubmed: 12955263
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Acta Dermatovenerol Croat. 2017 Jul;25(2):120-127
pubmed: 28871926
J Invest Dermatol. 1996 Nov;107(5):707-13
pubmed: 8875954
Br J Dermatol. 2015;172(5):1210-21
pubmed: 25677764
Hautarzt. 1999 Oct;50(10):715-22
pubmed: 10550357
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
J Eur Acad Dermatol Venereol. 2010 Sep;24(9):989-1004
pubmed: 20477920
Dermatology. 1999;199(3):213-22
pubmed: 10592400
Health Qual Life Outcomes. 2006 Sep 27;4:71
pubmed: 17005043
BMC Med Res Methodol. 2020 May 26;20(1):130
pubmed: 32456680
Arch Dermatol. 2009 Jul;145(7):774-80
pubmed: 19620558
Ceylon Med J. 2011 Mar;56(1):18-22
pubmed: 21542429
PLoS One. 2018 Mar 22;13(3):e0194492
pubmed: 29566036
Health Qual Life Outcomes. 2016 Feb 03;14:17
pubmed: 26841932
Semin Cutan Med Surg. 2013 Jun;32(2):101-9
pubmed: 24049968
Int J Dermatol. 2000 Dec;39(12):907-12
pubmed: 11168659
Acta Derm Venereol. 2000 Jul-Aug;80(4):272-6
pubmed: 11028860
Acta Derm Venereol. 2005;85(5):409-13
pubmed: 16159732
Pharmacoeconomics. 1998 Oct;14(4):405-22
pubmed: 10344908
Arch Dermatol. 1997 Nov;133(11):1433-40
pubmed: 9371029
Pediatr Dermatol. 2003 Nov-Dec;20(6):479-81
pubmed: 14651564
J Dermatolog Treat. 2014 Apr;25(2):106-9
pubmed: 22455447
Epidemiol Serv Saude. 2017 Jul-Sep;26(3):649-659
pubmed: 28977189
J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10
pubmed: 11443481
J Dermatol. 2002 Nov;29(11):693-8
pubmed: 12484430
Int J Dermatol. 2000 Nov;39(11):826-31
pubmed: 11123442
Arch Dermatol Res. 2009 Sep;301(8):561-71
pubmed: 19326133
Dermatology. 2004;209(1):14-20
pubmed: 15237262
Qual Life Res. 2018 May;27(5):1171-1179
pubmed: 29260445
Br J Dermatol. 1997 Feb;136(2):202-6
pubmed: 9068732
Psychol Assess. 2003 Dec;15(4):532-49
pubmed: 14692848
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
Med Clin (Barc). 2002 Jan 19;118(1):5-9
pubmed: 11803004
Am Fam Physician. 2001 Dec 1;64(11):1873-8
pubmed: 11764865
Br J Dermatol. 2015 Oct;173(4):1032-40
pubmed: 26099516